Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine againstCandida albicans
Authors:
- Alireza KhodavandiAKAlireza Khodavandi
- Fahimeh AlizadehFAFahimeh Alizadeh
- Nasim Aghai VandaNVNasim Aghai Vanda
- Golgis KarimiGKGolgis Karimi
- Pei Pei ChongPCPei Pei Chong
- 27 May 2014
- journal article
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 52 (12) , 1505-1509
Abstract
Candidiasis is a term describing infections by yeasts from the genus Candida, the majority Candida albicans. Treatment of such infections often requires antifungals such as the azoles, but increased use of these drugs has led to selection of yeasts with increased resistance to these drugs. Combination therapy would be one of the best strategies for the treatment of candidiasis due to increased resistance to azoles. The antifungal activities of fluconazole and terbinafine were evaluated in vitro alone and in combination using broth microdilution test and time kill study. Eventually the expression level of selected genes involved in ergosterol biosynthesis of Candida was evaluated using semi-quantitative RT-PCR. The obtained results showed the significant MICs ranging from 0.25 to 8 µg/mL followed by FICs ranged from 0.37 to 1 in combination with fluconazole/terbinafine. Our findings have demonstrated that the combination of fluconazole and terbinafine could also significantly reduce the expression of ERG1, 3, and 11 in the cell membrane of Candida in all concentrations tested ranging from 1.73- to 6.99-fold. This study was undertaken with the ultimate goal of finding the probable targets of fluconazole/terbinafine in C. albicans by looking at its effects on cell membrane synthesis.Keywords
This publication has 16 references indexed in Scilit:
- In Vitro Activity of Terbinafine Combined with Caspofungin and Azoles against Pythium insidiosumAntimicrobial Agents and Chemotherapy, 2009
- The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazoleMycoses, 2009
- Mecanismos de resistencia a los antifúngicos: levaduras y hongos filamentososRevista Iberoamericana de Micologia, 2008
- Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazoleJournal of Antimicrobial Chemotherapy, 2007
- Terbinafine Versus Itraconazole and Fluconazole in the Treatment of Vulvovaginal CandidiasisAmerican Journal of Therapeutics, 2006
- Synergistic Activities of Fluconazole and Voriconazole with Terbinafine against Four Candida Species Determined by Checkerboard, Time-Kill, and Etest MethodsAntimicrobial Agents and Chemotherapy, 2005
- Molecular basis of resistance to azole antifungalsTrends in Molecular Medicine, 2002
- Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial ResistanceClinical Microbiology Reviews, 1999
- Systemic Antifungal Therapy: Past, Present and FutureAnnals of Saudi Medicine, 1998
- Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibilityAntimicrobial Agents and Chemotherapy, 1995